Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from China Life Insurance Co ( (HK:2628) ).
China Life Insurance Company Limited has obtained approval from China’s National Financial Regulatory Administration for amendments to its Articles of Association that were previously passed at its September 2025 extraordinary general meeting. With the amendments now effective, the company has abolished its Board of Supervisors and transferred the supervisory functions and powers, as defined under PRC Company Law and regulatory rules, to the audit committee under the Board of Directors, marking a significant change in its corporate governance structure. All existing supervisors, including Cao Weiqing, Gu Haishan, Ye Yinglan and Dong Haifeng, have retired with no reported disagreements, and the company has expressed formal gratitude for their service, signaling an orderly transition that aligns oversight responsibilities more tightly with the board’s audit committee and may streamline governance processes for stakeholders.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$32.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major Chinese life insurer, providing a broad range of life insurance and related financial protection products to individual and institutional customers. Listed in Hong Kong, the company operates within China’s regulated financial sector and plays a significant role in the mainland life insurance market.
Average Trading Volume: 64,614,279
Technical Sentiment Signal: Buy
Current Market Cap: HK$1278.9B
See more insights into 2628 stock on TipRanks’ Stock Analysis page.